Markus Borner

7.4k total citations
126 papers, 5.6k citations indexed

About

Markus Borner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Markus Borner has authored 126 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Oncology, 38 papers in Pulmonary and Respiratory Medicine and 29 papers in Surgery. Recurrent topics in Markus Borner's work include Colorectal Cancer Treatments and Studies (40 papers), Cancer Treatment and Pharmacology (31 papers) and Gastric Cancer Management and Outcomes (18 papers). Markus Borner is often cited by papers focused on Colorectal Cancer Treatments and Studies (40 papers), Cancer Treatment and Pharmacology (31 papers) and Gastric Cancer Management and Outcomes (18 papers). Markus Borner collaborates with scholars based in Switzerland, United States and Germany. Markus Borner's co-authors include Daniel Betticher, Farzaneh Pirnia, Андреас Каппелер, Piercarlo Saletti, Jim Heighway, Silvia Vonlanthen, Mathias Gugger, E Schneider, A. Roth and Richard Herrmann and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Markus Borner

125 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Borner Switzerland 43 3.0k 1.8k 1.8k 1.1k 847 126 5.6k
Vincenzo Catalano Italy 40 3.1k 1.0× 1.6k 0.9× 1.4k 0.8× 1.2k 1.0× 866 1.0× 124 5.1k
Ying Huang United States 30 2.0k 0.7× 1.4k 0.7× 1.4k 0.8× 1.4k 1.2× 529 0.6× 105 4.4k
Ferdinando De Vita Italy 43 3.4k 1.1× 2.2k 1.2× 2.0k 1.1× 1.2k 1.0× 1.0k 1.2× 207 6.0k
Young Suk Park South Korea 41 4.0k 1.3× 2.3k 1.2× 1.3k 0.7× 1.9k 1.7× 1.1k 1.3× 227 6.3k
Teresa Troiani Italy 42 3.6k 1.2× 2.0k 1.1× 2.4k 1.4× 576 0.5× 1.1k 1.3× 183 5.9k
Michele Orditura Italy 44 3.4k 1.1× 2.1k 1.1× 1.9k 1.0× 1.2k 1.1× 1.0k 1.2× 181 6.1k
Kyung-Hun Lee South Korea 35 4.1k 1.4× 2.0k 1.1× 1.6k 0.9× 706 0.6× 1.5k 1.8× 216 6.0k
M. E. Scheulen Germany 36 2.6k 0.9× 1.2k 0.6× 2.3k 1.3× 422 0.4× 734 0.9× 178 5.5k
Jae Kyung Roh South Korea 30 4.2k 1.4× 1.8k 1.0× 1.1k 0.6× 1.2k 1.0× 862 1.0× 156 5.9k
Kun‐Huei Yeh Taiwan 38 3.4k 1.1× 2.3k 1.3× 2.2k 1.2× 1.4k 1.2× 914 1.1× 258 6.7k

Countries citing papers authored by Markus Borner

Since Specialization
Citations

This map shows the geographic impact of Markus Borner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Borner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Borner more than expected).

Fields of papers citing papers by Markus Borner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Borner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Borner. The network helps show where Markus Borner may publish in the future.

Co-authorship network of co-authors of Markus Borner

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Borner. A scholar is included among the top collaborators of Markus Borner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Borner. Markus Borner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rothgiesser, Karin, W. Schönfeld, Roger von Moos, et al.. (2025). Final Overall Survival Analysis of the Phase II SAKK 21/12 Trial of Transdermal CR1447 in Patients With Metastatic Breast Cancer. Clinical Breast Cancer. 25(6). 583–588. 1 indexed citations
2.
Lordick, Florian, Salah‐Eddin Al‐Batran, Dirk Arnold, et al.. (2023). German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer. Gastric Cancer. 27(1). 6–18. 3 indexed citations
3.
Siebenhüner, Alexander, Sara De Dosso, Daniel Helbling, et al.. (2021). Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article. Oncology Research and Treatment. 44(9). 485–494. 21 indexed citations
4.
Ribi, Karin, Solange Peters, Markus Borner, et al.. (2021). Pilot Testing of a Nurse-Led Basic Symptom Self-management Support for Patients Receiving First-Line Systemic Outpatient Anticancer Treatment. Cancer Nursing. 44(6). E687–E702. 5 indexed citations
5.
6.
Tausch, C., Silke Zimmermann, Roger von Moos, et al.. (2015). 1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10). European Journal of Cancer. 51. S313–S313. 1 indexed citations
7.
8.
Zlobec, Inti, K Dirschmid, Felix Offner, et al.. (2014). A multicentre inter-observer study on tumour budding using a 10HPF method in colorectal cancer: a study from the Swiss Association of Gastrointestinal Pathology (SAGIP). Bern Open Repository and Information System (University of Bern). 2 indexed citations
9.
Kasenda, Benjamin, Dieter Koeberle, Bernhard C. Pestalozzi, et al.. (2014). Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study. BMC Cancer. 14(1). 728–728. 37 indexed citations
10.
11.
Pirnia, Farzaneh, Michael Pawlak, Gerhard Thallinger, et al.. (2009). Novel functional profiling approach combining reverse phase protein microarrays and human 3‐D ex vivo tissue cultures: Expression of apoptosis‐related proteins in human colon cancer. PROTEOMICS. 9(13). 3535–3548. 26 indexed citations
12.
Wagner, Oliver J., Roman Inglin, Sonja Bisch-Knaden, et al.. (2008). Sirolimus and intraoperative hyperthermic peritoneal chemoperfusion with mitomycin-C do not impair healing of bowel anastomoses. Transplant International. 21(6). 554–563. 5 indexed citations
13.
Zwierzina, H. & Markus Borner. (2005). Klinische Entwicklung zielgerichteter molekularer Krebstherapeutika. Onkologie. 28(4). 35–39. 3 indexed citations
14.
Scheithauer, Werner, J McKendrick, S. Begbie, et al.. (2003). Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Annals of Oncology. 14(12). 1735–1743. 222 indexed citations
15.
Borner, Markus. (2001). Answering Patients' Needs: Oral Alternatives to Intravenous Therapy. The Oncologist. 6(90004). 12–16. 8 indexed citations
16.
Vonlanthen, Silvia, Jim Heighway, H. J. Altermatt, et al.. (2001). The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. British Journal of Cancer. 84(10). 1372–1376. 245 indexed citations
17.
18.
Sessa, Cristiana, Carla Minoia, A. Ronchi, et al.. (1998). Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days. Annals of Oncology. 9(12). 1315–1322. 45 indexed citations
19.
Maurer, Christoph A., Markus Borner, & Markus W. Büchler. (1997). Regional Chemotherapy of Gastro-Intestinal Cancer. Digestive Surgery. 14(1). 9–22. 5 indexed citations
20.
Cerny, Thomas, et al.. (1993). Oral bioavailability of mesna tablets. Cancer Chemotherapy and Pharmacology. 32(1). 78–81. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincenzo Catalano Breakdown of academic impact, for papers by Ying Huang Breakdown of academic impact, for papers by Ferdinando De Vita Breakdown of academic impact, for papers by Young Suk Park Breakdown of academic impact, for papers by Teresa Troiani Breakdown of academic impact, for papers by Michele Orditura Breakdown of academic impact, for papers by Kyung-Hun Lee Breakdown of academic impact, for papers by M. E. Scheulen Breakdown of academic impact, for papers by Jae Kyung Roh Breakdown of academic impact, for papers by Kun‐Huei Yeh
Rankless by CCL
2026